Role of [18F]FDG PET/CT in the management of follicular cell-derived thyroid carcinoma.

IF 3.5 2区 医学 Q2 ONCOLOGY Cancer Imaging Pub Date : 2024-10-28 DOI:10.1186/s40644-024-00791-8
Klaudia Zajkowska, Paulina Cegla, Marek Dedecjus
{"title":"Role of [<sup>18</sup>F]FDG PET/CT in the management of follicular cell-derived thyroid carcinoma.","authors":"Klaudia Zajkowska, Paulina Cegla, Marek Dedecjus","doi":"10.1186/s40644-024-00791-8","DOIUrl":null,"url":null,"abstract":"<p><p>Follicular cell-derived thyroid carcinomas constitute the majority of thyroid malignancies. This heterogeneous group of tumours includes well differentiated, poorly differentiated, and undifferentiated forms, which have distinct pathological features, clinical behaviour, and prognosis. Positron emission tomography with 2-[<sup>18</sup>F]fluoro-2-deoxy-D-glucose combined with computed tomography ([<sup>18</sup>F]FDG PET/CT) is an imaging modality used in routine clinical practice for oncological patients. [<sup>18</sup>F]FDG PET/CT has emerged as a valuable tool for identifying patients at high risk of poor clinical outcomes and for facilitating individualized clinical decision-making. The aim of this comprehensive review is to summarize current knowledge regarding the role of [<sup>18</sup>F]FDG PET/CT in primary diagnosis, treatment, and follow-up of follicular cell-derived thyroid carcinomas considering the degree of differentiation. Controversial issues, including significance of accidentally detected [<sup>18</sup>F]FDG uptake in the thyroid, the role of [<sup>18</sup>F]FDG PET/CT in the early assessment of response to molecular targeted therapies, and its prognostic value are discussed in detail.</p>","PeriodicalId":9548,"journal":{"name":"Cancer Imaging","volume":"24 1","pages":"147"},"PeriodicalIF":3.5000,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11514821/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Imaging","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s40644-024-00791-8","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Follicular cell-derived thyroid carcinomas constitute the majority of thyroid malignancies. This heterogeneous group of tumours includes well differentiated, poorly differentiated, and undifferentiated forms, which have distinct pathological features, clinical behaviour, and prognosis. Positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose combined with computed tomography ([18F]FDG PET/CT) is an imaging modality used in routine clinical practice for oncological patients. [18F]FDG PET/CT has emerged as a valuable tool for identifying patients at high risk of poor clinical outcomes and for facilitating individualized clinical decision-making. The aim of this comprehensive review is to summarize current knowledge regarding the role of [18F]FDG PET/CT in primary diagnosis, treatment, and follow-up of follicular cell-derived thyroid carcinomas considering the degree of differentiation. Controversial issues, including significance of accidentally detected [18F]FDG uptake in the thyroid, the role of [18F]FDG PET/CT in the early assessment of response to molecular targeted therapies, and its prognostic value are discussed in detail.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
18F]FDG PET/CT 在治疗滤泡细胞源性甲状腺癌中的作用。
滤泡细胞源性甲状腺癌占甲状腺恶性肿瘤的大多数。这组异质性肿瘤包括分化良好型、分化不良型和未分化型,它们具有不同的病理特征、临床表现和预后。2-[18F]氟-2-脱氧-D-葡萄糖正电子发射断层扫描结合计算机断层扫描([18F]FDG PET/CT)是一种用于肿瘤患者常规临床实践的成像模式。[18F]FDG正电子发射计算机断层扫描已成为一种有价值的工具,可用于识别临床疗效不佳的高风险患者,并促进个体化临床决策。本综述旨在总结[18F]FDG PET/CT在滤泡细胞源性甲状腺癌的初诊、治疗和随访中的作用,并考虑到分化程度。详细讨论了一些有争议的问题,包括甲状腺中意外检测到的[18F]FDG摄取的意义、[18F]FDG PET/CT在早期评估分子靶向疗法反应中的作用及其预后价值。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Cancer Imaging
Cancer Imaging ONCOLOGY-RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
CiteScore
7.00
自引率
0.00%
发文量
66
审稿时长
>12 weeks
期刊介绍: Cancer Imaging is an open access, peer-reviewed journal publishing original articles, reviews and editorials written by expert international radiologists working in oncology. The journal encompasses CT, MR, PET, ultrasound, radionuclide and multimodal imaging in all kinds of malignant tumours, plus new developments, techniques and innovations. Topics of interest include: Breast Imaging Chest Complications of treatment Ear, Nose & Throat Gastrointestinal Hepatobiliary & Pancreatic Imaging biomarkers Interventional Lymphoma Measurement of tumour response Molecular functional imaging Musculoskeletal Neuro oncology Nuclear Medicine Paediatric.
期刊最新文献
Clinical significance of visual cardiac 18F-FDG uptake in advanced non-small cell lung cancer. Nuclear medicine imaging in non-seminomatous germ cell tumors: lessons learned from the past failures. Seeing through "brain fog": neuroimaging assessment and imaging biomarkers for cancer-related cognitive impairments. Prediction of lateral lymph node metastasis with short diameter less than 8 mm in papillary thyroid carcinoma based on radiomics. A call for objectivity: Radiologists' proposed wishlist for response evaluation in solid tumors (RECIST 1.1).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1